Back to top

Phathom Completes Enrollment in Eosinophilic Esophagitis Trial

Phathom Pharmaceuticals ( ($PHAT) ) has shared an update. On June 23, 2026, Phathom Pharmaceuticals announced it has completed enrollment in its Ph...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Phathom Pharmaceuticals, Inc. (PHAT)